Inhaled nanoparticles—human-made specks so minuscule they can't be seen in conventional microscopes, found in thousands of common products—can cross a natural, protective barrier that normally protects fetuses, according ...
Apr 20, 2022
0
242
Scientists have developed a new nanotechnology approach for locating and removing the painful and dangerous lesions associated with endometriosis, a common gynecological condition in women of childbearing age.
Apr 18, 2022
0
185
A scientific team of scientists from NUST MISIS and Institute of Cytology and Genetics of SB RAS managed to create innovative bandages based on organic polymers and silver nanoparticles, which stimulate the healing of diabetic ...
Apr 13, 2022
0
2
Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to produce an immune response in animals on track with vaccines currently in clinical use. And with minor changes, Northwestern University researchers ...
Mar 22, 2022
0
128
Today, treatment methods are available for cancer that complement each other. Radiation therapy is frequently used, and can be combined with surgery and chemotherapy, for example. Although treatment with ionizing radiation ...
Mar 11, 2022
0
41
Investigators at Cedars-Sinai have identified a potential new therapy for COVID-19: a biologic substance created by reengineered human skin cells.
Mar 9, 2022
0
153
An influenza vaccine administered through the nose and constructed with nanoparticles that enhance immune response offers strong protection against different influenza virus strains, according to researchers in the Institute ...
Jan 29, 2022
0
276
UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma. ...
Jan 26, 2022
0
92
The lab of Youyang Zhao, Ph.D., from Stanley Manne Children's Research Institute at Ann & Robert H. Lurie Children's Hospital of Chicago developed a unique nanoparticle to deliver genome editing technology, including CRISPR/Cas9, ...
Jan 4, 2022
0
10
The research neutron source Hein Maier-Leibnitz (FRM II) at the Technical University of Munich (TUM) is playing an important role in the investigation of mRNA nanoparticles similar to the ones used in the COVID-19 vaccines ...
Dec 28, 2021
0
14
